{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27849000", "DateCompleted": {"Year": "2018", "Month": "05", "Day": "16"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "11", "Day": "16"}], "ELocationID": ["37151", "10.1038/srep37151"], "Language": ["eng"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "6", "PubDate": {"Year": "2016", "Month": "Nov", "Day": "16"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Irigenin, a novel lead from Western Himalayan chemiome inhibits Fibronectin-Extra Domain A induced metastasis in Lung cancer cells.", "Pagination": {"StartPage": "37151", "MedlinePgn": "37151"}, "Abstract": {"AbstractText": ["Several lines of evidence indicate that Fibronectin Extra Domain A (EDA) promotes metastatic capacity of tumor cells by engaging cell surface \u03b19\u03b21 integrins. This interaction mediated by the C-C loop of EDA activates pro-oncogenic signaling pathways leading to epithelial to mesenchymal transition (EMT) of tumor cells, thus signifying its importance in control of metastatic progression. In this context the present study was designed to explore the active compounds from selected ethno-medicinal plants of western Himalayan region for targeting EDA of Fibronectin in lung carcinoma cells. Structure based informatics for drug designing and screening was employed to generate a lead compound(s) feed that were conformationally and energetically viable. Out of 120 compounds selected, Irigenin showed best binding-affinity with C-C loop of EDA. Irigenin specifically targeted \u03b19\u03b21 and \u03b14\u03b21 integrin binding sites on EDA comprising LEU46, PHE47, PRO48, GLU58, LEU59 and GLN60 in its C-C loop as evaluated by energy decomposition per residue of Irigenin-EDA complex. In-vitro cell motility assays complemented with EDA knock-in and knockdown assays distinctively demonstrated that Irigenin prevents metastatic capacity of lung cancer cells by selectively blocking EDA. The results presented thus project Irigenin as a lead compound to overcome Fibronectin EDA induced metastatic progression in lung carcinoma cells."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, University of Kashmir, Srinagar (J and K), 190006, India."}, {"Identifier": [], "Affiliation": "Hybridoma Laboratory, National Institute of Immunology, New Delhi, 110067, India."}], "LastName": "Amin", "ForeName": "Asif", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, University of Kashmir, Srinagar (J and K), 190006, India."}, {"Identifier": [], "Affiliation": "Aaidah Life Sciences Pvt. Ltd., New Delhi, 110025, India."}], "LastName": "Chikan", "ForeName": "Naveed Anjum", "Initials": "NA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, University of Kashmir, Srinagar (J and K), 190006, India."}], "LastName": "Mokhdomi", "ForeName": "Taseem A", "Initials": "TA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, University of Kashmir, Srinagar (J and K), 190006, India."}, {"Identifier": [], "Affiliation": "Molecular Reproduction, Development &Genetics Lab, Indian Institute of Science, Bangalore, 560 012, India."}], "LastName": "Bukhari", "ForeName": "Shoiab", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, University of Kashmir, Srinagar (J and K), 190006, India."}], "LastName": "Koul", "ForeName": "Aabid M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, University of Kashmir, Srinagar (J and K), 190006, India."}], "LastName": "Shah", "ForeName": "Basit Amin", "Initials": "BA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Islamic Azad University, K\u0101zer\u016bn, Iran."}], "LastName": "Gharemirshamlu", "ForeName": "Fatemeh Rahimi", "Initials": "FR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, University of Kashmir, Srinagar (J and K), 190006, India."}], "LastName": "Wafai", "ForeName": "Asrar H", "Initials": "AH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hybridoma Laboratory, National Institute of Immunology, New Delhi, 110067, India."}], "LastName": "Qadri", "ForeName": "Ayub", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, University of Kashmir, Srinagar (J and K), 190006, India."}], "LastName": "Qadri", "ForeName": "Raies A", "Initials": "RA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Fibronectins"}, {"RegistryNumber": "0", "NameOfSubstance": "Integrin alpha Chains"}, {"RegistryNumber": "0", "NameOfSubstance": "Integrin beta1"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoflavones"}, {"RegistryNumber": "0", "NameOfSubstance": "Neoplasm Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "integrin alpha9"}, {"RegistryNumber": "6O4NX37350", "NameOfSubstance": "irigenin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "A549 Cells"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Epithelial-Mesenchymal Transition"}, {"QualifierName": ["antagonists & inhibitors", "genetics", "metabolism"], "DescriptorName": "Fibronectins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Integrin alpha Chains"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Integrin beta1"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Isoflavones"}, {"QualifierName": ["drug therapy", "genetics", "metabolism", "pathology"], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": [], "DescriptorName": "Neoplasm Metastasis"}, {"QualifierName": ["antagonists & inhibitors", "genetics", "metabolism"], "DescriptorName": "Neoplasm Proteins"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "Protein Domains"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Han S., Khuri F. R. & Roman J. Fibronectin stimulates non\u2013small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Cancer research 66, 315\u2013323, doi: 10.1158/0008-5472.can-05-2367 (2006).", "ArticleIdList": ["10.1158/0008-5472.can-05-2367", "16397245"]}, {"Citation": "Harima A. et al.. Fibronectin promotes cell proliferation of human pre-B cell line via its interactions with VLA-4 and VLA-5. Hematology 13, 236\u2013243, doi: 10.1179/102453308x348315 (2008).", "ArticleIdList": ["10.1179/102453308x348315", "18796250"]}, {"Citation": "Kornblihtt A. et al.. The fibronectin gene as a model for splicing and transcription studies. The FASEB Journal 10, 248\u2013257 (1996).", "ArticleIdList": ["8641558"]}, {"Citation": "White E. S., Baralle F. & Muro A. New insights into form and function of fibronectin splice variants. The Journal of pathology 216, 1\u201314, doi: 10.1002/path.2388 (2008).", "ArticleIdList": ["10.1002/path.2388", "PMC4630009", "18680111"]}, {"Citation": "Muro A. F. et al.. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. The Journal of cell biology 162, 149\u2013160, doi: 10.1083/jcb.200212079 (2003).", "ArticleIdList": ["10.1083/jcb.200212079", "PMC2172721", "12847088"]}, {"Citation": "Xiang L. et al.. The extra domain A of fibronectin increases VEGF-C expression in colorectal carcinoma involving the PI3K/AKT signaling pathway. Plos ONE 7, e35378, doi: 10.1371/journal.pone.0035378 (2012).", "ArticleIdList": ["10.1371/journal.pone.0035378", "PMC3322170", "22496919"]}, {"Citation": "Ou J. et al.. Fibronectin extra domain A (EDA) sustains CD133+/CD44+ subpopulation of colorectal cancer cells. Stem cell research 11, 820\u2013833, doi: 10.1016/j.scr.2013.05.009 (2013).", "ArticleIdList": ["10.1016/j.scr.2013.05.009", "PMC3917514", "23811539"]}, {"Citation": "Ou J.-J., Wu F. & Liang H.-J. Colorectal tumor derived fibronectin alternatively spliced EDA domain exserts lymphangiogenic effect on human lymphatic endothelial cells. Cancer biology & therapy 9, 186\u2013191, doi: 10.4161/cbt.9.3.10651 (2010).", "ArticleIdList": ["10.4161/cbt.9.3.10651", "20023414"]}, {"Citation": "Rybak J. N., Roesli C., Kaspar M., Villa A. & Neri D. The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases. Cancer Research 67, 10948\u201310957, doi: 10.1158/0008-5472.can-07-1436 (2007).", "ArticleIdList": ["10.1158/0008-5472.can-07-1436", "18006840"]}, {"Citation": "Liao Y.-F., Gotwals P. J., Koteliansky V. E., Sheppard D. & Van De Water L. The EIIIA Segment of Fibronectin Is a Ligand for Integrins \u03b19\u03b21 and \u03b14\u03b21Providing a Novel Mechanism for Regulating Cell Adhesion by Alternative Splicing. Journal of Biological Chemistry 277, 14467\u201314474, doi: 10.1074/jbc.m201100200 (2002).", "ArticleIdList": ["10.1074/jbc.m201100200", "11839764"]}, {"Citation": "Shinde A. V. et al.. Identification of the peptide sequences within the EIIIA (EDA) segment of fibronectin that mediate integrin \u03b19\u03b21-dependent cellular activities. Journal of Biological Chemistry 283, 2858\u20132870, doi: 10.1074/jbc.m708306200 (2008).", "ArticleIdList": ["10.1074/jbc.m708306200", "17967897"]}, {"Citation": "Ou J. et al.. Endothelial cell-derived fibronectin extra domain A promotes colorectal cancer metastasis via inducing epithelial\u2013mesenchymal transition. Carcinogenesis, doi: 10.1093/carcin/bgu090 (2014).", "ArticleIdList": ["10.1093/carcin/bgu090", "24743511"]}, {"Citation": "Villa A. et al.. A high\u2010affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo\u2010vasculature in vivo. International journal of cancer 122, 2405\u20132413, doi: 10.1002/ijc.23408 (2008).", "ArticleIdList": ["10.1002/ijc.23408", "18271006"]}, {"Citation": "Wieckowski S. et al.. Therapeutic efficacy of the F8-IL2 immunocytokine in a metastatic mouse model of lung adenocarcinoma. Lung Cancer 88, 9\u201315, doi: 10.1016/j.lungcan.2015.01.019 (2015).", "ArticleIdList": ["10.1016/j.lungcan.2015.01.019", "25682318"]}, {"Citation": "Chikan N. A., Bhavaniprasad V., Anbarasu K., Shabir N. & Patel T. N. From natural products to drugs for epimutation computer-aided drug design. Applied biochemistry and biotechnology 170, 164\u2013175, doi: 10.1007/s12010-013-0158-6 (2013).", "ArticleIdList": ["10.1007/s12010-013-0158-6", "23483409"]}, {"Citation": "Malik A. H., Khuroo A. A., Dar G. & Khan Z. Ethnomedicinal uses of some plants in the Kashmir Himalaya. Indian Journal of Traditional Knowledge 10, 362\u2013366 (2011)."}, {"Citation": "Lipinski C. A. Lead- and drug-like compounds: the rule-of-five revolution. Drug discovery today. Technologies 1, 337\u2013341, doi: 10.1016/j.ddtec.2004.11.007 (2004).", "ArticleIdList": ["10.1016/j.ddtec.2004.11.007", "24981612"]}, {"Citation": "Moroy G., Martiny V. Y., Vayer P., Villoutreix B. O. & Miteva M. A. Toward in silico structure-based ADMET prediction in drug discovery. Drug discovery today 17, 44\u201355, doi: 10.1016/j.drudis.2011.10.023 (2012).", "ArticleIdList": ["10.1016/j.drudis.2011.10.023", "22056716"]}, {"Citation": "Baldo B. Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses. OncoImmunology, 2, e26333, doi: 10.4161/onci.26333 (2013).", "ArticleIdList": ["10.4161/onci.26333", "PMC3827071", "24251081"]}, {"Citation": "Malaekeh-Nikouei B., Mousavi S. H., Shahsavand S., Mehri S., Nassirli H. & Moallem S. A. Assessment of Cytotoxic Properties of Safranal and Nanoliposomal Safranal in Various Cancer Cell Lines. Phytotherapy Research 27, 1868\u20131873, doi: 10.1002/ptr.4945 (2013).", "ArticleIdList": ["10.1002/ptr.4945", "23494763"]}, {"Citation": "Zhu T., Zhang W., Feng S. & Yu H. Emodin suppresses LPS-induced inflammation in RAW264.7 cells through a PPAR\u03b3-dependent pathway. International Immunopharmacology 34, 16\u201324, doi: 10.1016/j.intimp.2016.02.014 (2016).", "ArticleIdList": ["10.1016/j.intimp.2016.02.014", "26910236"]}, {"Citation": "Ahn K. S. et al.. Inhibitory effects of Irigenin from the rhizomes of Belamcanda chinensis on nitric oxide and prostaglandin E2 production in murine macrophage RAW 264.7 cells. Life Sciences 78, 2336\u20132342, doi: 10.1016/j.lfs.2005.09.041 (2006).", "ArticleIdList": ["10.1016/j.lfs.2005.09.041", "16307761"]}, {"Citation": "Amin A. et al.. Tectorigenin ablates the inflammation-induced epithelial\u2013mesenchymal transition in a co-culture model of human lung carcinoma. Pharmacological Reports 67, 382\u2013387, doi: 10.1016/j.pharep.2014.10.020 (2015).", "ArticleIdList": ["10.1016/j.pharep.2014.10.020", "25712668"]}, {"Citation": "Niimi T. et al.. NMR structure of human fibronectin EDA. Journal of biomolecular NMR 21, 281\u2013284, doi: 10.1023/a:1012947209393 (2001).", "ArticleIdList": ["10.1023/a:1012947209393", "11775745"]}, {"Citation": "Morris G. M. et al.. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of computational chemistry 30, 2785\u20132791, doi: 10.1002/jcc.21256 (2009).", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Hess B., Kutzner C., Van Der Spoel D. & Lindahl E. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of chemical theory and computation 4, 435\u2013447, doi: 10.1021/ct700301q (2008).", "ArticleIdList": ["10.1021/ct700301q", "26620784"]}, {"Citation": "Schu\u00c8ttelkopf A. W. & Van Aalten D. M. PRODRG: a tool for high-throughput crystallography of protein\u2013ligand complexes. Acta Crystallographica Section D: Biological Crystallography 60, 1355\u20131363, doi: 10.1107/s0907444904011679 (2004).", "ArticleIdList": ["10.1107/s0907444904011679", "15272157"]}, {"Citation": "Essmann U. et al.. A smooth particle mesh Ewald method. The Journal of chemical physics 103, 8577\u20138593, doi: 10.1063/1.470117 (1995).", "ArticleIdList": ["10.1063/1.470117"]}, {"Citation": "Baker N. A., Sept D., Joseph S., Holst M. J. & McCammon J. A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proceedings of the National Academy of Sciences 98, 10037\u201310041 (2001).", "ArticleIdList": ["PMC56910", "11517324"]}, {"Citation": "Kumari R., Kumar R. & Lynn A. g_mmpbsa \u2014 A GROMACS Tool for High-Throughput MM-PBSA Calculations. Journal of chemical information and modeling 54, 1951\u20131962, doi: 10.1021/ci500020m (2014).", "ArticleIdList": ["10.1021/ci500020m", "24850022"]}, {"Citation": "DeLano W. L. The PyMOL Molecular Graphics System, Version 1.8 Schr\u00f6dinger, LLC, Cambridge, MA. https://www.pymol.org (2002)."}, {"Citation": "Laskowski R. A. & Swindells M. B. LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery. Journal of chemical information and modeling 51, 2778\u20132786, doi: 10.1021/ci200227u (2011).", "ArticleIdList": ["10.1021/ci200227u", "21919503"]}, {"Citation": "Accelrys Software Inc. Discovery Studio Modeling Environment, Version 3.5, San Diego, CA, USA. http://www.accelrys.com (2012)."}, {"Citation": "Turner, P. J. XMGRACE, Version 5.1. 19. Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology, Beaverton, OR, USA. http://plasma-gate.weizmann.ac.il/Grace/ (2005)."}, {"Citation": "Williams T. & Kelley C. Gnuplot 4.4: an interactive plotting program. http://www.gnuplot.info/ (2011)."}, {"Citation": "Amin A. et al.. Investigating the pharmacological potential of Iris kashmiriana in limiting growth of epithelial tumors. Pharmacognosy Journal 5, 170\u2013175, doi: 10.1016/j.phcgj.2013.07.003 (2013).", "ArticleIdList": ["10.1016/j.phcgj.2013.07.003"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "6", "Day": "30"}, {"Year": "2016", "Month": "10", "Day": "25"}, {"Year": "2016", "Month": "11", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "11", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "11", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["27849000", "PMC5111083", "10.1038/srep37151", "srep37151"]}}], "PubmedBookArticle": []}